Clindamycin release determined by high performance liquid chromatography from a novel low-cost local drug delivery system: A new potential treatment option for chronic osteomyelitis

D. Frank, G. Montskó, I. Juricskay, B. Borsiczky, G. Cseh, B. Kocsis, T. Nagy, A. K. Nagy, G. L. Kovács, A. Miseta

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Osteomyelitis continues to be a severe problem worldwide, causing plenty of hospital admissions and entailing vast expenses. previously, we developed a low-cost polymethyl-methacrylate (pmmA)-sorbitol based capsule system for local long-term drug delivery. in the present study we aimed to test the in vitro release of clindamycin capsules by high performance liquid chromatography. By the end of the clinically relevant period (42 days), the capsules released 70-100% of their load. furthermore, the release kinetics suggested that an effective antimicrobial concentration may be maintained within the target area. Our findings indicate that these newly developed capsules may be a versatile device for local clindamycin delivery by providing efficient release and reducing financial burdens.

Original languageEnglish
Pages (from-to)282-284
Number of pages3
JournalJournal of Chemotherapy
Volume23
Issue number5
DOIs
Publication statusPublished - Oct 2011

    Fingerprint

Keywords

  • Antibiotic release
  • Chronic osteomyelitis
  • Clindamycin
  • Infection
  • Local drug delivery
  • Local therapy
  • Polymethyl-methacrylate

ASJC Scopus subject areas

  • Oncology
  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Cite this